Mark Wilterding
CIK: 0002107187
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RxSight, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
258.8K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
258.8K shares- - Sep 2, 2026RXST
RxSight, Inc.
Sale(S)Direct7.8K shares at avg. $6.96$54K - Aug 31, 2026RXST
RxSight, Inc.
Exercise(M)Direct20.4K shares- - Feb 28, 2026RXST
RxSight, Inc.
Exercise(M)Direct20.4K shares- - Feb 28, 2026RXST
RxSight, Inc.
Tax Payment(F)Direct8.1K shares at avg. $7.61$61K - Jan 12, 2026RXST
RxSight, Inc.
Award(A)DirectRestricted Stock Unit
163.5K shares- - Jan 12, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
258.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 258,770 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 258,770 | - | - | Direct |
| Sep 2, 2026 | RXST RxSight, Inc. | Sale(S) | 7,765 | $6.96 | $54,044 | Direct |
| Aug 31, 2026 | RXST RxSight, Inc. | Exercise(M) | 20,441 | - | $0 | Direct |
| Feb 28, 2026 | RXST RxSight, Inc. | Exercise(M) | 20,441 | - | $0 | Direct |
| Feb 28, 2026 | RXST RxSight, Inc. | Tax Payment(F) | 8,068 | $7.61 | $61,397 | Direct |
| Jan 12, 2026 | RXST RxSight, Inc. | Award(A) Restricted Stock Unit | 163,528 | - | - | Direct |
| Jan 12, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 258,770 | - | - | Direct |
1-8 of 8 transactions
About Wilterding Mark
Wilterding Mark (SEC CIK 0002107187) files insider reports with the SEC as Chief Financial Officer of RxSight, Inc. (RXST).
Signal8 holds 5 ownership filings by Wilterding Mark (1 Form 3, 4 Form 4), filed between Jan 30, 2026 and Sep 9, 2026. Those filings report 8 transactions, from Jan 12, 2026 to Sep 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilterding Mark's filings is in ALISO VIEJO, CA.
Recent filings by Wilterding Mark
- Sep 5, 2026: Grant or award of RXST derivative securities (Form 4, code A).
- Sep 5, 2026: Disposition to issuer transaction of RXST derivative securities (Form 4, code D).
- Sep 2, 2026: Open-market sale of RXST shares (Form 4, code S).
- Aug 31, 2026: Option exercise of RXST shares (Form 4, code M).
- Feb 28, 2026: Option exercise of RXST shares (Form 4, code M).
Other insiders filing for RxSight, Inc. (RXST)
- Weinberg Eric
- Kurtz Ronald M MD, Chief Medical Officer
- Goldshleger Ilya, Chief Operating Officer
- Mottiwala Aziz, President and CEO
- Warner Robert Keith, Director
- PALMISANO ROBERT J, Director